04:08 AM EDT, 09/27/2024 (MT Newswires) -- Cue Biopharma ( CUE ) said late Thursday it priced a public offering of 11.6 million common shares with accompanying warrants to purchase 2.9 million shares at a combined price of $0.50.

The company said it is also offering to certain investors, in lieu of common stock, pre-funded warrants for 12.4 million shares with accompanying warrants for 3.1 million shares at a combined price of $0.499.

The gross proceeds of the offering are expected to be about $12 million.

The offering is anticipated to close around Sept. 30.